Skip to main content
SpringerLink
Log in
Book cover

Pulmonary Involvement in Patients with Hematological Malignancies pp 41–45Cite as

Epidemiology of Respiratory Events in Patients with HM (Not Including ICU)

  • Chapter
  • First Online:

  • 1090 Accesses

Abstract

Pulmonary complications in patients with hematological malignancies typically are associated with severe morbidity and frequently result in fatal outcome. The majority of these events are pneumonias caused by microbial pathogens, among which invasive fungal infections are the most life-threatening subgroup. Other microorganisms primarily resistant to broad-spectrum antibacterial agents, particularly viruses, Pneumocystis jiroveci, mycobacteria and multi-resistant bacteria, must be addressed by adequate diagnostic procedures, but important differential diagnoses apart from infectious diseases must be taken into consideration as well, first of all pulmonary side effects from cytotoxic drugs, radiotherapy or pulmonary involvement by the underlying malignancy. Clinical outcome may be favorable also in patients with severe respiratory failure, so that intensive care referral and invasive cardiorespiratory intervention are ethically justified in patients whose clinical course is not expected to be unequivocally fatal.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Ahmed S, Siddiqui AK, Rossoff L, Sison CP, Rai KR (2003) Pulmonary complications in chronic lymphocytic leukemia. Cancer 98:1912–1917

    Article  PubMed  Google Scholar 

  2. Azoulay E, Darmon M, Delclaux C et al (2002) Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med 30:781–786

    Article  PubMed  Google Scholar 

  3. Azoulay E, Thiery G, Chevret S et al (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83:360–370

    Article  Google Scholar 

  4. Bodey G, Bueltmann B, Duguid W et al (1992) Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 11:99–109

    Article  PubMed  CAS  Google Scholar 

  5. Caillot D, Casasnovas O, Bernard A et al (1997) Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 15:139–147

    PubMed  CAS  Google Scholar 

  6. Camus P, Costabel U (2005) Drug-induced respiratory disease in patients with hematological diseases. Semin Respir Crit Care Med 26:458–81

    Article  PubMed  Google Scholar 

  7. Carratalà J, Rosón B, Fernández-Sevilla A, Alcaide F, Gudiol F (1998) Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome. Arch Intern Med 158:868–872

    Article  PubMed  Google Scholar 

  8. Cazzadori A, di Perri G, Todeschini G et al (1995) Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest 107:101–106

    Article  PubMed  CAS  Google Scholar 

  9. Chamilos G, Luna M, Lewis RE et al (2006) Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 91:986–989

    PubMed  Google Scholar 

  10. Chaoui D, Legrand O, Roche N et al (2004) Incidence and prognostic value of respiratory events in acute leukemia. Leukemia 18:670–675

    Article  PubMed  CAS  Google Scholar 

  11. Chemaly RF, Torres HA, Aguilera EA et al (2007) Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis 44:964–967

    Article  PubMed  Google Scholar 

  12. Cornillet A, Camus C, Nimubona S et al (2006) Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 43:577–584

    Article  PubMed  CAS  Google Scholar 

  13. Danés C, Gonzalez-Martin J, Pumarola T et al (2002) Pulmonary infiltrates in immunosuppressed patients: analysis of a diagnostic protocol. J Clin Microbiol 40: 2134–2140

    Article  PubMed  Google Scholar 

  14. Daniels CE, Myers JL, Utz JP, Markovic SN, Ryu JH (2007) Organizing pneumonia in patients with hematologic malignancies: a steroid-responsive lesion. Respir Med 101: 162–168

    Article  PubMed  Google Scholar 

  15. Ewig S, Glasmacher A, Ulrich B et al (1998) Pulmonary infiltrates in neutropenic patients with acute leukemia during chemotherapy. Chest 114:444–451

    Article  PubMed  CAS  Google Scholar 

  16. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE (2005) Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 352:1749–1759

    Article  PubMed  CAS  Google Scholar 

  17. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K (1996) Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 33:23–32

    Article  PubMed  CAS  Google Scholar 

  18. Jules-Elysee K, Stover DE, Yahalom J, White DA, Gulati SC (1992) Pulmonary complications in lymphoma patients treated with high-dose therapy autologous bone marrow transplantation. Am Rev Respir Dis 146:485–491

    PubMed  CAS  Google Scholar 

  19. Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106: 2258–2266

    Article  PubMed  Google Scholar 

  20. Lass-Flörl C, Resch G, Nachbaur D (2007) The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin Infect Dis 45:e101–e104

    Article  PubMed  Google Scholar 

  21. Lin MY, Weinstein RA, Hota B (2008) Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrob Agents Chemother 52:3188–3194

    Article  PubMed  CAS  Google Scholar 

  22. Lin SJ, Schranz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32:358–366

    Article  PubMed  CAS  Google Scholar 

  23. Martino R, Ramila E, Rabella N et al (2003) Respiratory virus infections in adults with hematologic malignancies: a prospective study. Clin Infect Dis 36:1–8

    Article  PubMed  Google Scholar 

  24. Maschmeyer G, Beinert T, Buchheidt D et al (2009) Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients. 2008 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Oncology. Eur J Cancer 45:2462–2472

    Article  PubMed  CAS  Google Scholar 

  25. Maschmeyer G, Bertschat FL, Häusler E et al (2003) Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year period. Eur J Cancer 39:783–792

    Article  PubMed  CAS  Google Scholar 

  26. Maschmeyer G, Link H, Hiddemann W et al (1994) Pulmonary infiltrations in febrile neutropenic patients. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter trial. Cancer 73:2296–2304

    Article  PubMed  CAS  Google Scholar 

  27. Mossad SB, Longworth DL, Goormastic M, Serkey JM, Keys TF, Bolwell BJ (1996) Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 18:265–271

    PubMed  CAS  Google Scholar 

  28. Pagano L, Caira M, Candoni A et al (2006) The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91: 1068–1075

    PubMed  Google Scholar 

  29. Raad II, Whimbey EE, Rolston KVI et al (1996) A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients. Cancer 77:1386–1394

    Article  PubMed  CAS  Google Scholar 

  30. Reich G, Mapara MY, Reichardt P, Dörken B, Maschmeyer G (2001) Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 27:525–529

    Article  PubMed  CAS  Google Scholar 

  31. Rossini F, Verga M, Pioltelli P et al (2000) Incidence and outcome of pneumonia in patients with acute leukemia receiving first induction therapy with anthracycline-containing regimens. Haematologica 85:1255–1260

    PubMed  CAS  Google Scholar 

  32. Safdar A, Rolston KV (2007) Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin Infect Dis 45:1602–1609

    Article  PubMed  Google Scholar 

  33. Samonis G, Kontoyiannis DP (2001) Infectious complications of purine analog therapy. Curr Opin Infect Dis 14: 409–413

    Article  PubMed  CAS  Google Scholar 

  34. Schiel X, Link H, Maschmeyer G (2006) A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients. Infection 34:118–126

    Article  PubMed  CAS  Google Scholar 

  35. Shorr AF, Susla GM, O’Grady NP (2004) Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes. Chest 125:260–271

    Article  PubMed  Google Scholar 

  36. Suzuki HI, Asai T, Tamaki Z, Hangaishi A, Chiba S, Kurokawa M (2008) Drug-induced hypersensitivity syndrome with rapid hematopoietic reconstitution during treatment for acute myeloid leukemia. Haematologica 93: 469–470

    Article  PubMed  Google Scholar 

  37. Torres HA, Aguilera EA, Mattiuzzi GN et al (2007) Characteristics and outcome of Respiratory Syncytial Virus infection in patients with leukemia. Haematologica 92:1216–1223

    Article  PubMed  Google Scholar 

  38. Vehreschild JJ, Böhme A, Buchheidt D et al (2007) A double-blind trial on prophylactic voriconazole or placebo during induction chemotherapy for acute myelogenous leukaemia. J Infect 55:445–449

    Article  PubMed  Google Scholar 

  39. Walsh TJ, Anaissie EJ, Denning DW et al (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327–360

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Oncology and Palliative Care, Center for Hematology, Oncology and Radiotherapy, Klinikum Ernst von Bergmann, Charlottenstr. 72, D-14467, Potsdam, Germany

    Georg Maschmeyer

Authors
  1. Georg Maschmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georg Maschmeyer .

Editor information

Editors and Affiliations

  1. Service de Réanimation Médicale, Hôpital Saint Louis, Avenue Claude Vellefaux 1, Paris, 75010, France

    Elie Azoulay

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Maschmeyer, G. (2011). Epidemiology of Respiratory Events in Patients with HM (Not Including ICU). In: Azoulay, E. (eds) Pulmonary Involvement in Patients with Hematological Malignancies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-15742-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-15742-4_4

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-15741-7

  • Online ISBN: 978-3-642-15742-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation